In This Story IMVT -4.58% Immunovant, Inc. has submitted its 10-Q filing for the quarterly period ended September 30, 2024. Suggested Reading It's not just Bitcoin: 3 'altcoins' also rising on Trump's election win The Federal Reserve cuts interest rates again as the jobs market cools Wendy’s needs AI to handle its $1 Frosty demand Sales of Novo Nordisk’s blockbuster weight loss drug Wegovy continue to soar CC Share Subtitles Off English Share this Video Facebook Twitter Email Reddit Link Sales

Tag-uri: Facebook Bitcoin Twitter